focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 May 2007 07:02

Phorm Inc21 May 2007 Embargoed for release until 7a.m. 21/05/07 Directorate Change Phorm, Inc ("Phorm" or the "Company") Further to the Company's previous announcement on 8th March 2007, the Company(AIM: PHRM and PHRX) is pleased to announce today that David Dorman, ChristopherLawrence and Virasb Vahidi have joined the Board of Phorm, Inc. David Dorman has been an advisor to the Company since July 2006. He is currentlysenior advisor and partner at global private equity firm Warburg Pincus and waspreviously chairman and chief executive officer of AT&T Corp. Before that, hewas CEO of Concert, the global venture created by AT&T and BritishTelecommunications. Mr Dorman serves on the Boards of Motorola, Inc., CVSCorporation, Firethorn Mobile, LLC, and YUM! Brands, Inc. Christopher Lawrence is currently vice chairman of Rothschild, Inc. Prior tojoining Rothschild in 2005, Mr Lawrence was chief strategic officer of CreditSuisse Group as well as a vice chairman of Credit Suisse First Boston. He beganhis investment banking career at Salomon Brothers in 1981. Virasb Vahidi, who is Phorm's chief operating officer, is an internationalbusiness executive with a distinguished career encompassing senior finance,strategy and planning roles in global companies including AT&T Corp. andAmerican Airlines, Inc. Mr Vahidi was most recently senior vice president ofcorporate strategy and development at AT&T, where he was the financial architectof the AT&T Corp/SBC Communications, Inc. merger and co-leader of theintegration team. As also notified on 8th March, David Svendsen, chairman, and Dave Gwozdz havestepped down from the Board of the Company. Dave Gwozdz will remain as US seniorvice president, Business Development and Sales for Phorm. Commenting on the new Board directors, Kent Ertugrul, chairman and CEO of Phorm,said: "We are delighted to welcome Dave, Chris and Virasb to the Board. Theyeach bring complementary skills and experience of an exceptional calibre. Theirwealth of expertise and knowledge will be invaluable as we continue to developour business." "We are grateful to David Svendsen and Dave Gwozdz for their contribution to theBoard and wish them well in the future." Save as set out in the Appendix, there are no further details in relation to theabove appointments which require disclosure under paragraph (g) of Schedule 2 tothe AIM Rules. Ends For EnquiriesPhorm, Inc. +44 870 405 7722Kent Ertugrul (Chairman & Chief Executive) Edelman Financial PR +44 20 7344 1325Paul Lockstone +44 7876 685200 Canaccord Adams Limited +44 20 7050 6500Nominated AdviserMark WilliamsAndrew Chubb Notes to editors Phorm, Inc. was formerly known as 121Media Inc. Appendix Information provided in accordance with paragraph g of Schedule 2 to the AIMrules: (i) the director's full name and age together with any previous names; David Wyatt Dorman, Age 53, None (ii) the names of all companies and partnerships of which the director has beena director or partner at any time in the previous five years, indicating whetheror not the director is still a director or partner; Name of Company Period of DirectorshipAT&T 2002-2006CVS 2006-PresentFirethorn Mobile, LLC 2006-PresentMotorola 2006-PresentSABRE 1999-2002SAIC 1998-2002Scientific Atlanta 1998-2006Yum! Brands 2005-Present (i) the director's full name and age together with any previous names; Christopher Rueckert Lawrence, Age 53, None (ii) the names of all companies and partnerships of which the director has beena director or partner at any time in the previous five years, indicating whetheror not the director is still a director or partner; Name of Company Period of Directorship:120 East End Avenue 1997 (approximately)-Present (i) the director's full name and age together with any previous names; Virasb Vahidi, Age 40, None (ii) the names of all companies and partnerships of which the director has beena director or partner at any time in the previous five years, indicating whetheror not the director is still a director or partner; None This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Jun 20127:00 amRNSAGM Statement
1st Jun 20127:00 amRNS£20m equity fundraising into Phorm China
1st Jun 20127:00 amRNSIntention to Re-Domicile
22nd May 20127:00 amRNSPhorm Announces AGM Notice & Proposed Board Change
21st Mar 20127:00 amRNSAppointment of Nominated Adviser and Joint Broker
5th Mar 20127:00 amRNSTransfer of Shares
1st Mar 20127:00 amRNSTransfer of Shares
28th Dec 20117:00 amRNSDirector Dealing
12th Dec 201110:10 amRNSTransfer of Shares
7th Dec 201110:19 amRNSTransfer of Shares
2nd Dec 20112:02 pmRNSTR-1: Notification of Major Interest in Shares
2nd Dec 201112:16 pmRNSTransfer of Shares
11th Nov 20117:30 amRNSIssue of Equity
4th Nov 20117:30 amRNSIssue of Equity
21st Oct 20113:28 pmRNSIssue of Equity
20th Oct 20114:14 pmRNSTransfer of Shares
7th Oct 20112:00 pmRNSBlock Admission Return
30th Sep 20117:00 amRNSInterim Results for Six Months Ended 30 June 2011
28th Sep 20117:00 amRNSProduct Launch
30th Jun 20117:00 amRNSAnnual Financial Report
8th Apr 201112:00 pmRNSBlock Admission Return
30th Mar 20117:00 amRNSTR-1: Notification of Major Interest in Shares
22nd Mar 20117:00 amRNSPlacing and operating update
2nd Mar 201112:00 pmRNSTransfer of Shares
1st Feb 201110:14 amRNSResult of AGM
6th Jan 20117:15 amRNSOption Grant and Modification
6th Jan 20117:05 amRNSAdvisory Board Appointment - Juan Villalonga
24th Dec 20108:11 amRNSNotice of AGM
17th Dec 20109:11 amRNSIssue of convertible secured loan notes
8th Oct 20105:25 pmRNSBlock Admission Return
30th Sep 20107:00 amRNSInterim results
22nd Sep 20107:00 amRNSUpdate on Commercial Deployment in Brazil
17th Aug 20103:42 pmRNSCorrection re Share Transfer
16th Aug 20103:58 pmRNSShare Transfer
16th Aug 20108:50 amRNSDirectorate Change
30th Jul 20101:00 pmRNSTransfer of Shares
23rd Jul 201011:17 amRNSDirectorate Change
16th Jul 20104:25 pmRNSTransfer of Shares
9th Jul 20107:00 amRNSTransfer of Shares
7th Jul 20104:55 pmRNSDirector/PDMR Shareholding
7th Jul 20102:19 pmRNSPlacing of Shares
30th Jun 20102:17 pmRNSAnnual Report & Accounts Notification
30th Jun 20107:00 amRNSPreliminary Results
28th Jun 20107:00 amRNSNotification of results
8th Jun 20102:05 pmRNSChange in name of Nominated Adviser
30th Apr 20101:08 pmRNSGrant of options
9th Apr 20105:25 pmRNSBlock Admission Return
26th Mar 20107:00 amRNSCommercial Deployment in Brazil
28th Jan 20104:37 pmRNSNotification of Major Interest in Shares
11th Jan 20104:28 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.